Abstract CT167: A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors Conference Paper uri icon

authors

  • Goh, Jeffrey
  • Gao, Ben
  • Markman, Ben
  • Gan, Hui
  • Voskoboynik, Mark
  • Wu, Yi-Long
  • Guo, Jun
  • Zhou, Qing
  • Zhao, Jun
  • Chen, Cheng
  • Qiu, Jingjun
  • Xu, Yingying
  • Yang, Liu
  • Millward, Michael

publication date

  • July 1, 2019